Moderna Inc on late Thursday sought emergency use authorization from US health regulators for a second Covid-19 booster shot, as a surge in cases in some parts of the world fuels fears of another wave of the pandemic.
Covid-19 vaccine maker Moderna does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin work in a few weeks, Chief Executive Stephane Bancel said in an interview.
The European Medicines Agency (EMA) on Friday approved a new manufacturing site in France for the production of Moderna Inc's Covid-19 vaccine.
Hackers who stole documents from the EU's drug regulator have leaked some online and "manipulated" them in a bid to damage public trust in coronavirus vaccines, the watchdog said Friday.
Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the US Food and Drug Administration, welcome news to a nation with a staggering Covid-19 death toll ...
Moderna Inc's Covid-19 vaccine appeared set for regulatory authorization this week after US Food and Drug Administration staff endorsed it as safe and effective in documents released Tuesday.
President Donald Trump's controversial coronavirus adviser resigned Monday, while hopes for a first wave of vaccinations before the end of 2020 received a further boost with an announcement from US firm Moderna.
Moderna Inc will apply for US and European emergency authorization for its Covid-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns, the company said.
The first batch of an approved Covid-19 vaccine is expected to arrive in Qatar by the end of this year, a senior health official has reiterated. Dr Hamad Eid al-Romaihi, manager of Health Protection and Communicable Disease Control under the Ministry of Public Health (MoPH)
Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission:
Moderna Inc's experimental vaccine is 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second US drugmaker to report results that far exceed expectations.
The US Centers for Disease Control and Prevention (CDC) said on Wednesday that Covid-19 vaccines may not be initially recommended for children, when they become available.